Vycor Medical (VYCO) Free Cash Flow Growth (5y) (2015 - 2026)
Vycor Medical (VYCO) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.99% |
| Dec 31, 2025 | 46.70% |
| Sep 30, 2025 | 16.07% |
| Jun 30, 2025 | 24.35% |
| Mar 31, 2025 | 19.83% |
| Dec 31, 2024 | -7.58% |
| Sep 30, 2024 | 23.31% |
| Jun 30, 2024 | 56.50% |
| Mar 31, 2024 | 15.75% |
| Dec 31, 2023 | -15.11% |
| Sep 30, 2023 | 18.99% |
| Jun 30, 2023 | 15.99% |
| Mar 31, 2023 | 16.61% |
| Dec 31, 2022 | 30.19% |
| Sep 30, 2022 | 15.12% |
| Jun 30, 2022 | -3.76% |
| Mar 31, 2022 | 24.17% |
| Dec 31, 2021 | 17.36% |
| Sep 30, 2021 | -44.77% |
| Jun 30, 2021 | 19.34% |